The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.

MLA

Cavallari, Lh, et al. “The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.” CTS: Clinical & Translational Science, vol. 10, no. 3, May 2017, pp. 143–46. EBSCOhost, https://doi.org/10.1111/cts.12456.

APA

Cavallari, L., Beitelshees, A., Blake, K., Dressler, L., Duarte, J., Elsey, A., Eichmeyer, J., Empey, P., Franciosi, J., Hicks, J., Holmes, A., Jeng, L., Lee, C., Lima, J., Limdi, N., Modlin, J., Obeng, A., Petry, N., Pratt, V., & Skaar, T. (2017). The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting. CTS: Clinical & Translational Science, 10(3), 143–146. https://doi.org/10.1111/cts.12456

Chicago

Cavallari, Lh, Al Beitelshees, Kv Blake, Lg Dressler, Jd Duarte, A Elsey, Jn Eichmeyer, et al. 2017. “The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.” CTS: Clinical & Translational Science 10 (3): 143–46. doi:10.1111/cts.12456.